This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

YRC Worldwide: Midday Volume Movers

Stocks in this article: YRCW

NEW YORK ( TheStreet) -- Several small-cap stocks were moving on above-average volume during Tuesday's session.

YRC Worldwide (YRCW) continued its recent slide, falling by 25 cents, or 18.9%, to $1.07. The drop comes a day after the company launched a debt exchange offer that, if successful, will cause massive dilution of shares but will likely help the company avert bankruptcy. Volume topped 18.5 million shares, compared to the 50-day average daily volume of 10 million, according to the Nasdaq.

U.S. Energy Corp. (USEG) jumped by 80 cents, or 15.6%, to $5.92 after Brigham Exploration (BEXP) late Monday said a BCD Farms well produced approximately 1,776 barrels of oil equivalent per day during an early 24 hour flow back period. Brigham has a participation agreement with U.S. Energy for the BCD Farms well. Volume topped 1 million shares, compared to the 50-day average daily volume of 619,000, according to the Nasdaq.

Hemispherx Biopharma (HEB) plummeted by 24 cents, or 18%, to $1.09 after the company said it plans to complete all outstanding queries from the Food and Drug Administration regarding its application for Ampligen, an experimental therapeutic, during the final two months of 2009. Volume topped 5.6 million shares, compared to the three-month average daily volume of 4.6 million, according to Yahoo! Finance.

Chelsea Therapeutics (CHTP) fell by 64 cents, or 21.8%, to $2.30 after the company late Monday said it plans to meet with U.S. drug regulators seeking permission to change the primary endpoint of an ongoing phase III study of the droxidopa in patients with orthostatic hypotension. As a result, data from this study won't be ready for release this quarter, but will be delayed into early next year, pending the outcome of the FDA meeting, the company said. Volume topped 1.5 million shares, compared to the 50-day average daily volume of 2.3 million, according to the Nasdaq.

Carmike Cinemas (CKEC) dropped by $2.62, or 27.4%, to $6.96 after the company late Monday swung to a third-quarter loss of $1.62 a share while revenue stayed flat in the quarter at $122.4 million. Merriman Curhan Ford downgraded the stock to neutral from buy following the report. Volume topped 200,000 shares, compared to the 50-day average daily volume of 52,000, according to the Nasdaq.

-- Written by Robert Holmes in New York.

Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs